EP
Enanta Pharmaceuticals Inc
🇺🇸XNAS.ENTAUnited StatesHealthcare
$12.73USDup +0.44 (+3.58%)OpenDelayed5:03 PM
Price$12.73+0.44 (+3.58%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US29251M1062
- CUSIP
- 29251M106
Company
- Employees
- 120
- Headquarters
- Watertown, United States
- Website
- https://www.enanta.com
- CEO
- Dr. Jay R. Luly Ph.D.
Market
- Shares outstanding
- 29.1M
- Market cap
- $370.77M
Highlights
- Market cap
- $354.46M
- EPS LTM
- -$2.17
- P/E LTM
- -6.64
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $65.26M+0.7%up year on year
- Net income
- -$63.23M+31.28%up year on year
- Gross margin
- 94.33%+0.17%up year on year
- Free cash flow
- -$36.94M+15.22%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.